Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA

Identifieur interne : 003209 ( Main/Exploration ); précédent : 003208; suivant : 003210

EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA

Auteurs : W. M Watkins [Kenya] ; J. D Lury [Kenya] ; D. Kariuki [Kenya] ; D. K Koech [Kenya] ; J. A Oloo [Kenya] ; M. Mosoba [Royaume-Uni] ; M. Mjomba [Royaume-Uni] ; H. M Gilles [Royaume-Uni]

Source :

RBID : ISTEX:CE2CE131910A311E7C1F41FA689DC6C3B5B178AA

English descriptors

Abstract

Abstract: Halofantrine hydrochloride given to 46 Kenyan children with falciparum malaria at 10 mg/kg for two doses, and to 60 other children at 8 mg/kg for three doses, resulted in rapid parasite clearance, mean parasite clearance times being 45·4 h and 54·8 h, respectively. In-vitro chemosensitivity tests showed that most infections were due to chloroquine-resistant parasites, and that parasite maturation was inhibited by considerably lower concentrations of halofantrine than of chloroquine.

Url:
DOI: 10.1016/S0140-6736(88)92538-X


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA</title>
<author>
<name sortKey="Watkins, W M" sort="Watkins, W M" uniqKey="Watkins W" first="W. M" last="Watkins">W. M Watkins</name>
</author>
<author>
<name sortKey="Lury, J D" sort="Lury, J D" uniqKey="Lury J" first="J. D" last="Lury">J. D Lury</name>
</author>
<author>
<name sortKey="Kariuki, D" sort="Kariuki, D" uniqKey="Kariuki D" first="D" last="Kariuki">D. Kariuki</name>
</author>
<author>
<name sortKey="Koech, D K" sort="Koech, D K" uniqKey="Koech D" first="D. K" last="Koech">D. K Koech</name>
</author>
<author>
<name sortKey="Oloo, J A" sort="Oloo, J A" uniqKey="Oloo J" first="J. A" last="Oloo">J. A Oloo</name>
</author>
<author>
<name sortKey="Mosoba, M" sort="Mosoba, M" uniqKey="Mosoba M" first="M" last="Mosoba">M. Mosoba</name>
</author>
<author>
<name sortKey="Mjomba, M" sort="Mjomba, M" uniqKey="Mjomba M" first="M" last="Mjomba">M. Mjomba</name>
</author>
<author>
<name sortKey="Gilles, H M" sort="Gilles, H M" uniqKey="Gilles H" first="H. M" last="Gilles">H. M Gilles</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CE2CE131910A311E7C1F41FA689DC6C3B5B178AA</idno>
<date when="1988" year="1988">1988</date>
<idno type="doi">10.1016/S0140-6736(88)92538-X</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-41DR55RW-K/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000980</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000980</idno>
<idno type="wicri:Area/Istex/Curation">000980</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F71</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F71</idno>
<idno type="wicri:doubleKey">0140-6736:1988:Watkins W:efficacy:of:multiple</idno>
<idno type="wicri:Area/Main/Merge">003280</idno>
<idno type="wicri:Area/Main/Curation">003209</idno>
<idno type="wicri:Area/Main/Exploration">003209</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA</title>
<author>
<name sortKey="Watkins, W M" sort="Watkins, W M" uniqKey="Watkins W" first="W. M" last="Watkins">W. M Watkins</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Kenya</country>
<wicri:regionArea>Biomedical Sciences Research Centre, Kenya Medical Research Institute (KEMRI), Nairobi;</wicri:regionArea>
<wicri:noRegion>Nairobi;</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lury, J D" sort="Lury, J D" uniqKey="Lury J" first="J. D" last="Lury">J. D Lury</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Kenya</country>
<wicri:regionArea>Wellcome Trust Research Laboratories, Nairobi;</wicri:regionArea>
<wicri:noRegion>Nairobi;</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kariuki, D" sort="Kariuki, D" uniqKey="Kariuki D" first="D" last="Kariuki">D. Kariuki</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Kenya</country>
<wicri:regionArea>Clinical Research Centre, KEMRI, Nairobi;</wicri:regionArea>
<wicri:noRegion>Nairobi;</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Koech, D K" sort="Koech, D K" uniqKey="Koech D" first="D. K" last="Koech">D. K Koech</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Kenya</country>
<wicri:regionArea>Biomedical Sciences Research Centre, Kenya Medical Research Institute (KEMRI), Nairobi;</wicri:regionArea>
<wicri:noRegion>Nairobi;</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Oloo, J A" sort="Oloo, J A" uniqKey="Oloo J" first="J. A" last="Oloo">J. A Oloo</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Kenya</country>
<wicri:regionArea>Clinical Research Centre, KEMRI, Nairobi;</wicri:regionArea>
<wicri:noRegion>Nairobi;</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mosoba, M" sort="Mosoba, M" uniqKey="Mosoba M" first="M" last="Mosoba">M. Mosoba</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Vector Borne Diseases, Kenya Ministry of Health;</wicri:regionArea>
<wicri:noRegion>Kenya Ministry of Health;</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool;</wicri:regionArea>
<wicri:noRegion>Liverpool;</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mjomba, M" sort="Mjomba, M" uniqKey="Mjomba M" first="M" last="Mjomba">M. Mjomba</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Kilifi District Hospital;</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gilles, H M" sort="Gilles, H M" uniqKey="Gilles H" first="H. M" last="Gilles">H. M Gilles</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1988">1988</date>
<biblScope unit="volume">332</biblScope>
<biblScope unit="issue">8605</biblScope>
<biblScope unit="page" from="247">247</biblScope>
<biblScope unit="page" to="250">250</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Alkaline phosphatase</term>
<term>Alternative drugs</term>
<term>Aspirin</term>
<term>Bilirubin</term>
<term>Body weight</term>
<term>Cell count</term>
<term>Chloroquine</term>
<term>Clinical chemistry</term>
<term>Clinical trials</term>
<term>Dos</term>
<term>Falciparum</term>
<term>Falciparum infections</term>
<term>Falciparum malana</term>
<term>Falciparum malaria</term>
<term>First study</term>
<term>First week</term>
<term>Halofantrine</term>
<term>Halofantrine hydrochloride</term>
<term>Halofantrine therapy</term>
<term>Healthy humans</term>
<term>Infarction</term>
<term>Kenya</term>
<term>Kenya coast</term>
<term>Kenya ministry</term>
<term>Kilifi</term>
<term>Kilifi district hospital</term>
<term>Kilifi study</term>
<term>Lake malawi</term>
<term>Liverpool school</term>
<term>Malaria</term>
<term>Malawi</term>
<term>Malindi</term>
<term>Malindi study</term>
<term>Myocardial infarction</term>
<term>Normal conditions</term>
<term>Normal limits</term>
<term>Normal range</term>
<term>Parasitaemia</term>
<term>Parasite</term>
<term>Parasite clearance time</term>
<term>Parasite counts</term>
<term>Parasite sensitivity</term>
<term>Phenanthrene methanol compound halofantrine</term>
<term>Physical examination</term>
<term>Plasmodium</term>
<term>Plasmodium falciparum</term>
<term>Proc natl acad</term>
<term>Prostacyclin</term>
<term>Prostaglandin</term>
<term>Prostaglandin endoperoxides</term>
<term>Rieckmann</term>
<term>Rieckmann microtest</term>
<term>Rieckmann microtests</term>
<term>Schizont maturation</term>
<term>Second trial</term>
<term>Secondary prevention</term>
<term>Serum aspartate</term>
<term>Single dose</term>
<term>Test concentrations</term>
<term>Tropical medicine</term>
<term>Unstable angina</term>
<term>Vesterqvist</term>
<term>Vivo production</term>
<term>Wellcome trust</term>
<term>West africa</term>
<term>West shore</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Halofantrine hydrochloride given to 46 Kenyan children with falciparum malaria at 10 mg/kg for two doses, and to 60 other children at 8 mg/kg for three doses, resulted in rapid parasite clearance, mean parasite clearance times being 45·4 h and 54·8 h, respectively. In-vitro chemosensitivity tests showed that most infections were due to chloroquine-resistant parasites, and that parasite maturation was inhibited by considerably lower concentrations of halofantrine than of chloroquine.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Kenya</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Kenya">
<noRegion>
<name sortKey="Watkins, W M" sort="Watkins, W M" uniqKey="Watkins W" first="W. M" last="Watkins">W. M Watkins</name>
</noRegion>
<name sortKey="Kariuki, D" sort="Kariuki, D" uniqKey="Kariuki D" first="D" last="Kariuki">D. Kariuki</name>
<name sortKey="Koech, D K" sort="Koech, D K" uniqKey="Koech D" first="D. K" last="Koech">D. K Koech</name>
<name sortKey="Lury, J D" sort="Lury, J D" uniqKey="Lury J" first="J. D" last="Lury">J. D Lury</name>
<name sortKey="Oloo, J A" sort="Oloo, J A" uniqKey="Oloo J" first="J. A" last="Oloo">J. A Oloo</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Mosoba, M" sort="Mosoba, M" uniqKey="Mosoba M" first="M" last="Mosoba">M. Mosoba</name>
</noRegion>
<name sortKey="Gilles, H M" sort="Gilles, H M" uniqKey="Gilles H" first="H. M" last="Gilles">H. M Gilles</name>
<name sortKey="Mjomba, M" sort="Mjomba, M" uniqKey="Mjomba M" first="M" last="Mjomba">M. Mjomba</name>
<name sortKey="Mosoba, M" sort="Mosoba, M" uniqKey="Mosoba M" first="M" last="Mosoba">M. Mosoba</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003209 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003209 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CE2CE131910A311E7C1F41FA689DC6C3B5B178AA
   |texte=   EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021